Drug Profile
Research programme: small molecule therapeutics - Evotec SE/Fraunhofer IME
Latest Information Update: 25 Sep 2019
Price :
$50
*
At a glance
- Originator Evotec AG; Fraunhofer Institute for Molecular Biology and Applied Ecology
- Developer Evotec SE; Fraunhofer Institute for Molecular Biology and Applied Ecology
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for research development in Undefined in Germany
- 08 Jul 2014 Evotec AG and Fraunhofer Institute for Molecular Biology and Applied Ecology enters into collaboration for the development of small molecule therapeutics
- 08 Jul 2014 Early research in Undefined indication in Germany (unspecified route)